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Abstract 
Organophosphate (OP) pesticides exert their toxic effects by cholinesterase 
inhibition and the consequent prolongation of the undesirable effects of 
accumulation of acetylcholine. However, sustained cholinesterase inhibition 
through sustained sub-acute administration of organophosphates leads to 
disappearance of the initial signs of toxicity, termed behavioral tolerance. 
The present study examines if the levels of amine neurotransmitter 
substances in rat brain regions are altered during acute and sub-acute 
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treatment with an organophosphate pesticide. Phosphamidon under different 
time intervals was used with due reference to behavioral tolerance. Acute (1 
day) and sub-acute (1 day, 7 days, 15 days) doses of phosphamidon were 
administered by oral intubation. Different brain regions were isolated at 
specific time intervals. The levels of epinephrine (EP), nor-epinephrine (NE), 
dopamine (DA) and serotonin (5-HT) and the activity levels of the enzyme 
monoamine oxidase (MAO) were determined at the specified time intervals 
under both acute and sub-acute dose treatments. The amine levels showed 
differential variations in different brain regions during acute and sub-acute 
treatments, implying regional changes in catecholamine and serotonin levels 
during the development of OP-induced behavioral tolerance. Monoamine 
oxidase activity was in general inhibited in all the brain regions under both 
acute and sub-acute treatments. The results indicate the involvement of non-
cholinergic mechanisms during behavioral tolerance.  
Key words: Behavioral tolerance, Biogenic amines, Phosphamidon, Rat 
brain  
Introduction 
Organophosphate (OP) compounds act on the cholinergic system by 
inhibiting cholinesterases, leading to marked increase of acetylcholine level 
in central and peripheral synapses (Arnal et al., 1990). The signs of their 
toxicity include tremors, convulsions, lachrymation, defecation etc. Sub-
chronic and chronic exposure to low doses of majority of OP compounds 
leads to the development of behavioral tolerance (Russell and Overstreet, 
1987; Swamy et al., 1993). Biochemical and alterations were noticed along 
with changes in receptor mechanisms during tolerance development (Russell 
et al., 1986; Van Dongen and Wolthuis, 1989). Cholinergic system is mainly 
involved in this process of tolerance. 
Biogenic amines such as epinephrine, nor-epinephrine, dopamine and 
serotonin   (5-Hydroxytryptamine, 5-HT) act as neurotransmitters in different 
areas of rat brain. The relation between their metabolism in the CNS and 
cerebral function varies in different brain regions under different conditions 
(Krnjevic, 1974). Monoamine oxidase (MAO), an enzyme that converts 
catecholamines to their corresponding aldehydes, controls the levels of 
biogenic amines (Kadir and Knowles, 1981). Organophosphate (OP) 
pesticides such as monocrotophos, dichlorvos and phosphamidon 
significantly inhibit both MAO-A and MAO-B activities in mitochondria of 
rat brain neurons, suggesting that the OP pesticides could also exert their 
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effects through alterations in the biogenic amines (Nag and Nandy, 2001). 
Earlier study by Magda et al. (2001) on the effects of the OP compound 
chlorpyrifos and the carbamate insecticide carbaryl on the activity of brain 
MAO-A and on the platelet uptake of  5-HT reported that there was a 
decrement in 5-HT uptake but no change in MAO-A activity. Since acute 
carbaryl administration inhibited acetylcholinesterase (AChE) and 
butyrylcholinesterase (BuChE) activities also, interference with the 5-HT 
system by chlorpyrifos and carbaryl could presumably contribute to the 
toxicity of these pesticides (Magda et al., 2001).   
Marquis (1985) pointed out that the effects of OP compounds may not be 
attributed to the inhibition of AChE alone but to non-cholinergic segments as 
well. It has been reported that OP compounds affect non-cholinergic 
neurotransmitters such as serotonin and catecholamines (Glisson et al., 1974; 
Koehn and Karczmar, 1978; Morgan and Pfeil, 1979; Prioux-Guyonneau et 
al., 1982; Coudray-Lucas et al., 1983). The discovery of a variety of 
neurotransmitters and their involvement in a number of neurological and 
behavioral disorders (Hornykiewicz, 1975; Enna, 1981; Seeman, 1981) 
suggest their possible role of OP-induced tolerance in addition to cholinergic 
systems. Sivam et al. (1983) reported that dopamine and gamma amino 
butyric acid (GABA) play a major role in the development of behavioral 
tolerance to diisopropylfluorophosphate (DFP). Repeated treatment with 
phosphorothionate (Siddiqui, 2003) indicated that the activity of membrane-
bound target enzymes aspartate (AAT) and alanine (AlAT) aminotransferase 
increased significantly in serum and kidney, whereas it decreased 
significantly in liver and lung after 45 and 90 days of treatment. It also 
caused significant inhibition of erythrocyte AChE, a target enzyme for 
organophosphorus compounds, revealing its effect on normal synaptic 
transmission (Siddiqui, 2003). 
Phosphamidon was detected by thin-layer chromatography from various CNS 
regions of rats intoxicated with it, revealing that regions with higher gray 
matter composition showed greater uptake of phosphamidon compared to 
those rich in white matter (Naqvi and Hasan, 1990). It has also been accepted 
that changes in other neurotransmitters might have a role in behavioral 
tolerance to OP compounds (Fernando et al., 1984). In the present study, the 
levels of biogenic amines and activity levels of MAO were estimated during 
acute and sub-acute treatment with phosphamidon in different brain regions 
of rats during different time intervals, and with reference to the development 
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of behavioral tolerance. The study indicates the possible involvement of non-
cholinergic mechanisms during the development of tolerance to OP 
compounds. 
Methodology 
Animal selection and maintenance                        
Over 400 male Wistar rats (150 ± 20 g) were used in this experiment. A rat 
colony was maintained in the Department. The rats were kept in the animal 
house at 25 ± 2˚ C with a photoperiod of 12:12 hr light-dark cycle. The rats 
were fed with standard pellet diet (Hindustan Lever Ltd., Bombay) and water 
ad libitum. The rats were handled and sacrificed according to the ethical 
guidelines for animal protection and welfare bearing the CPCSEA 
438/01/a/cpcsea/dt 17.07.2001 in its resolution No: 9/IAEC/svu/2001/dt 
04.03.2002. 
Selection of Chemical and Dosage Regimen 
Phosphamidon was obtained from CIBA-GEIGY, Mumbai in liquid form, 
which is highly soluble in water. Water was therefore selected as a vehicle 
for phosphamidon administration by oral intubation. Six batches of rats with 
six in each batch were taken and median lethal dose (LD50; 13.29 mg/kg body 
wt/day) was determined by probit method of Finney (1971).   An oral dose of 
1/3 LD50 (4.433 mg/kg body wt/day) was selected for daily dosing for 15 
days as sub- acute dose. Similarly 1/2 LD50 (6.64 mg/kg body wt/day) was 
selected as acute dose. 
Biochemical Estimations 
Different areas of the brain such as cerebral cortex (CC), cerebellum (CB), 
hippocampus (HC), pons-medulla (PM), and striatum (ST) were isolated 
using standard anatomical marks (Glowinski and Iverson, 1966). The levels 
of epinephrine, nor-epinephrine and dopamine and serotonin were estimated 
by the method of Kari et al. (1978). Monoamine oxidase activity was 
estimated by the method of Green and Haughton (1961).  
Results 
The results showed region-specific alterations in the levels of EP, NE, DA 
and 5-HT and activity of monoamine oxidase during the development of 
tolerance to phosphamidon toxicity (Tables 1, 2, 3, 4, and 5). Epinephrine 
levels decreased in CB, CC and PM and increased in ST and HC both during 
acute and sub-acute phosphamidon treatment (Table 1). The NE content 
decreased in CC and PM under both acute and sub-acute treatments. In CB it 
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showed a decrease under acute treatment, while showing a decrease at 1 day 
and an increase at 7 and 15 days under sub-acute treatment. The NE levels 
were elevated in ST and HC in both the treatment groups (Table 2). 
Dopamine levels were elevated in all brain regions except in pons-medulla 
during acute and sub-acute dose treatments (Table 3). Serotonin content was 
elevated in all areas under acute treatment. It showed an increase in ST and 
HC whereas it decreased in CC, CB and PM under sub-acute dose (Table 4). 
MAO activity was inhibited in all the brain regions under acute dose. Under 
sub-acute treatment it increased in CC and PM, while showing a decrease in 
CB, ST and HC (Table 5). 
Discussion 
Changes in the cholinesterase system during development of tolerance to the 
organophosphate insecticides have been documented (Sahitya Chetan et al., 
2009). The changes in the levels of biogenic amines and MAO activity in 
different brain regions of behaviorally tolerant animals indicate in general the 
possibility of parallel neurochemical pathways that are capable of taking over 
the functions of cholinergic system when the latter is impaired. Hence it is 
conceivable that tolerance to the OP-ChE inhibitors might involve alterations 
in other transmitter systems accompanying cholinergic impairment during 
acute and sub-acute OP treatment. 
Neurochemical studies on the effects organophosphate toxicity other than the 
common ACh-AChE system are gaining momentum in recent times. Though 
there is no direct evidence that these systems are involved in the phenomenon 
of behavioral tolerance, earlier reports suggested the possible involvement of 
non-cholinergic mechanisms in behavioral tolerance during OP toxicity 
(Sivam et al., 1983; Ho and Hoskins, 1986). OP compounds disrupt the 
cholinergic system and in turn elevate ACh levels, which may lead to 
changes in other transmitter systems as a corollary to the primary change 
with reference to AChE inhibition.  
Ali et al. (1980) reported a decrease in the NE and DA content in the cerebral 
hemisphere, cerebellum and brainstem of rat after daily dichlorvos treatment. 
The elevation in the levels of DA in cerebral cortex and cerebellum and 
decreased EP and NE levels in these regions in the present study suggests a 
compensatory increase in DA accompanying the decrease in EP and NE.  It 
was also reported earlier that the excessive levels of DA in striatum and 
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hippocampus might inhibit the release of NE in other regions (Hope et al., 
1976). 
Acute dose of phosphamidon elevated the 5-HT levels in all regions except in 
pons-medulla. MAO activity was estimated to examine if the activity of this 
catecholamine-metabolizing enzyme varies with the changes in EP, NE and 
DA levels. MAO activity was inhibited in all the brain regions after 
phosphamidon treatment in spite of variable changes in the levels of NE, EP 
and DA. It showed non-significant elevation in cerebral cortex and decreased 
in cerebellum, striatum and hippocampus during sub-acute dosing. Similarly 
a decrease in MAO activity was observed in rats during OP and carbamate 
toxicity (Kadir and Knowles, 1981). Phosphamidon significantly inhibited 
both MAO-A and MAO-B activities in rat brain mitochondria, suggesting 
that the mechanism of action of OP pesticides is through phosphorylation of 
serine residue present in active centre of MAO (Nag and Nandy, 2001). 
Organophosphate insecticide chlorpyrifos and the carbamate insecticide 
carbaryl showed their effects where MAO-A activity was not affected. Acute 
carbaryl administration caused AChE and BuChE inhibition and also a 
significant decrease in 5-HT uptake but no change in MAO-A. Interference 
with the 5-HT system by chlorpyrifos and carbaryl could contribute to the 
toxicity. (Tzivanidou et al., 2001) 
A decrease in NE and EP levels and MAO activity was also observed in rats 
following sub-acute and acute doses of monocrotophos (Borkowska, 1980). It 
was also reported that OP compounds may exert effects on neuronal function 
by phosphorylating enzymes and proteins other than AChE. Treatment with 
the toxicant phosphorothionate revealed that the AAT and AlAT activities 
increased in serum but decreased significantly in liver and lung, indicating 
necrosis of these tissues. However, in case of kidney the activities of these 
enzymes increased parallel to serum significantly, which was suggested to be 
due to an increased synthesis of these enzymes, as a possible adaptive 
response to the stress of the toxicant. These biomarker enzymes can be 
detected rapidly and hence may be used for the prediction and diagnosis of 
pesticide insults (Siddiqui, 2003). OP insecticides have also been shown to 
inhibit rat MAO activity, suggesting that interference with catecholamine 
synthesis and its metabolism may be one of the non-cholinergic effects of OP 
(Kadir and Knowles, 1981).  
Though the alterations in catecholamine levels may offer a compensatory 
response to excessive cholinergic stimulation resulting from OP intoxication, 
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the interplay of different catecholamines and their regulation in different 
brain regions is difficult to understand and needs an extensive study. It may 
be assumed that the elevation in the catecholamine and serotonin levels might 
correlate to the phosphorylation of specific enzymes related to the synthesis 
of non–cholinergic transmitters, which might be responsible for acute and 
chronic effects of anti-ChE insecticides.  
Conclusion 
The present study indicates that although cholinergic impairment is the 
primary target of OP compounds with eventual development of behavioral 
tolerance, it is possible that the phenomenon of behavioral tolerance may also 
be related to the operation of non-cholinergic mechanisms. 
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Table 1:  Changes in epinephrine (EP) (µg/g wet wt of tissue) content during 
acute and sub- acute phosphamidon treatment in rats. 
 
Brain region 
 Sub-acute dose treatment periods 































































































































Values are mean ± SD (n = 6). 
Values in parentheses are percent changes from control. 
Changes are significant at least at P < 0.05 in SNK test. 
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Table 2:  Changes in Nor-epinephrine (NE) (µg/g wet wt of tissue) content 
during acute and sub-acute phosphamidon treatment in rats 
 
Values are mean ± SD (n = 6). 
Values in parentheses are percent changes from control. 
Changes are significant at least at P < 0.05 in SNK test. 









 Sub-acute dose treatment periods 

























































































































   ± 0.353 
(-1.48)* 
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Table 3:  Changes in dopamine (DA) (µg/g wet wt of tissue) content during 
acute and sub-acute phosphamidon treatment in rats 
 
Values are mean ± SD (n = 6). 
Values in parentheses are percent changes from control. 
Changes are significant at least at P < 0.05 in SNK test. 
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0.289 












































































   ± 0.053 
(-15.79)* 
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Table 4: Changes in serotonin (5-HT) (µg/g wet wt of tissue) content during 




 Sub-acute dose treatment periods 








































    ± 0.074 
 
0.631 












































































   ± 0.082 
(-21.85) 
Values are mean ± SD (n = 6). 
Values in parentheses are percent changes from control. 
Changes are significant at least at P < 0.05 in SNK test. 
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Table 5: Changes in monoamine oxidase activity (µmoles of p-
hydroxyphenyl-acetaldehyde formed/mg protein/h) during acute and sub-
acute phosphamidon treatment in rats 
 
Brain region 
 Sub-acute dose treatment periods 









































 ± 0.133 
 
1.150 












































































   ± 0.218 
(12.29)* 
Values are mean ± SD (n = 6). 
Values in parentheses are percent changes from control. 
Changes are significant at least at P < 0.05 in SNK test. 
* Not significant.  
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